Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

304
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
304
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

11.3K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
11.3K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

279
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
279
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

367
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
367
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

207
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
207
Inflammatory Response01:28

Inflammatory Response

2.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA Group.

American journal of hematology·2026
Same author

The Effect of 6-Gingerol on Human AML Cell Lines.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology·2026
Same author

Tumor Cell-Derived Microparticles Induced by Methotrexate Reprogram Neutrophil Antitumor Response via Lysosomal ROS-Mediated Degranulation.

Molecular cancer research : MCR·2025
Same author

Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial.

Blood·2025
Same author

Precision prediction of venetoclax-azacitidine treatment efficacy in acute myeloid leukemia via integrative drug screening and machine learning.

Cell reports. Medicine·2025
Same author

Anti-CD19 CAR-T cell therapy in relapsed/refractory t(8;21) acute myeloid leukemia with aberrant CD19 expression.

Frontiers in immunology·2025

Related Experiment Video

Updated: Jul 15, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K

Causal relationships between circulating inflammatory factors and IgA vasculitis: a bidirectional Mendelian

Jiading Qin1,2, Ling Zhang1,2, Bo Ke2,3

  • 1Medical College of Nanchang University, Nanchang, China.

Frontiers in Immunology
|September 27, 2023
PubMed
Summary

This study found that higher levels of C-reactive protein (CRP) and Interleukin-8 (IL-8) causally increase the risk of IgA vasculitis (IgAV). Genetically predicted IgA vasculitis was linked to lower TNF-beta levels.

Keywords:
C-reactive proteinIgA vasculitisMendelian randomizationbidirectionalcirculating inflammatory regulators

More Related Videos

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

6.9K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

4.9K

Related Experiment Videos

Last Updated: Jul 15, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K
Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

6.9K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

4.9K

Area of Science:

  • Immunology
  • Genetics
  • Epidemiology

Background:

  • IgA vasculitis (IgAV) is an immune-mediated condition with an unclear etiology.
  • Understanding the role of inflammatory factors in IgAV pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the causal relationship between inflammatory factors and IgA vasculitis (IgAV) using a bidirectional Mendelian randomization approach.
  • To identify specific inflammatory markers that may contribute to the development or progression of IgAV.

Main Methods:

  • Conducted a bidirectional summary-level Mendelian randomization (MR) analysis.
  • Utilized genome-wide association study (GWAS) data for C-reactive protein (CRP), procalcitonin (PCT), 41 inflammatory regulators, and IgAV from the FinnGen Biobank (216,569 participants).
  • Employed inverse-variance weighted (IVW) as the primary MR method, with MR-Egger, weighted median, and weighted mode for sensitivity analyses.

Main Results:

  • Elevated C-reactive protein (CRP) levels were causally associated with an increased risk of IgA vasculitis (IgAV) across multiple MR methods (e.g., IVW OR=1.41, P=0.04).
  • Higher levels of Interleukin-8 (IL-8) were also significantly linked to an increased risk of IgAV (IVW OR=1.42, P=0.02).
  • Genetically predicted IgAV showed an association with decreased levels of TNF-beta (IVW estimate β=-0.093, P=0.033); no significant associations were found for other inflammatory factors.

Conclusions:

  • This bidirectional Mendelian randomization study provides robust evidence for a causal role of CRP and IL-8 in the pathogenesis of IgA vasculitis (IgAV).
  • The findings suggest that IgAV may influence TNF-beta levels.
  • Targeting specific inflammatory pathways, such as those involving CRP and IL-8, holds potential for future therapeutic interventions in IgAV management.